Serra Ventures

Ryvit develops an integration software that delivers seamless flow of data between premise and software used in the construction industry. The software integrates software application to enterprise resource product, customer relationship management, e-commerce, social apps, and specialty industry-specific system without exhausting development resources, empowering companies to experience the ease of intelligent integrations, driving profit through automation and optimization of the applications in use. Ryvit is headquartered in Saint Louis, Missouri.

Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.

Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, founded in 2008. The company specializes in developing a rapid and label-free biological assay platform that measures clinical and point-of-care samples. This innovative platform employs diagnostic arrayed imaging reflectometry (AIR) to enable the simultaneous detection of hundreds of analytes from a single drop of fluid, allowing healthcare professionals to conduct sophisticated tests with high sensitivity and specificity. By significantly reducing the time required for testing, Adarza BioSystems aims to enhance diagnostic capabilities in various healthcare settings.

Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

OPER, LLC is a mobile payment and rewards platform based in St. Louis, Missouri, established in 2015. The company offers a comprehensive app that enhances the dining experience by enabling users to order food, make payments, and earn rewards through cashback discounts. This platform not only facilitates transactions for restaurant customers but also allows various establishments to participate in the rewards program. Users can store their payment cards within the app and benefit from earning rewards across multiple categories, including food, clothing, and electronics.

Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.

Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, founded in 2008. The company specializes in developing a rapid and label-free biological assay platform that measures clinical and point-of-care samples. This innovative platform employs diagnostic arrayed imaging reflectometry (AIR) to enable the simultaneous detection of hundreds of analytes from a single drop of fluid, allowing healthcare professionals to conduct sophisticated tests with high sensitivity and specificity. By significantly reducing the time required for testing, Adarza BioSystems aims to enhance diagnostic capabilities in various healthcare settings.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.

Tunespeak, LLC operates a musician-to-fan loyalty platform that rewards users for engaging with music and related content. Founded in 2011 and based in St. Louis, Missouri, the platform allows users to earn points by listening to music, watching videos, viewing photos, and sharing content with friends. Users can accumulate points not only for their own activity but also for enabling their friends to participate in contests or raffles for every song, picture, and video shared. Through this unique engagement model, Tunespeak aims to enhance the connection between musicians and their fans while offering incentives such as tickets, experiences, and merchandise.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.

Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, founded in 2008. The company specializes in developing a rapid and label-free biological assay platform that measures clinical and point-of-care samples. This innovative platform employs diagnostic arrayed imaging reflectometry (AIR) to enable the simultaneous detection of hundreds of analytes from a single drop of fluid, allowing healthcare professionals to conduct sophisticated tests with high sensitivity and specificity. By significantly reducing the time required for testing, Adarza BioSystems aims to enhance diagnostic capabilities in various healthcare settings.